University of Yamanashi   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Kofu Japan (2002)

Organization Overview

First Clinical Trial
2002
NCT00232375
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Third Department of Internal Medicine, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi | University of Yamanashi | University of Yamanashi, First Deparment of Surgery | University of Yamanashi, First Department of Surgery | University of Yamanashi Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Esophageal Neoplasms (Phase 2)

Head and Neck Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 9